Amundi Asset Management US’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-173
Closed -$9K 1504
2020
Q3
$9K Hold
173
﹤0.01% 1528
2020
Q2
$9K Buy
173
+71
+70% +$3.83K ﹤0.01% 1545
2020
Q1
$5K Sell
102
-2,730
-96% -$157K ﹤0.01% 1550
2019
Q4
$156K Sell
2,832
-3,124
-52% -$170K ﹤0.01% 1518
2019
Q3
$300K Sell
5,956
-2,007
-25% -$101K ﹤0.01% 1390
2019
Q2
$401K Sell
7,963
-1,119
-12% -$54.3K ﹤0.01% 1380
2019
Q1
$422K Sell
9,082
-10,623
-54% -$538K ﹤0.01% 1336
2018
Q4
$967 Sell
19,705
-10,597
-35% -$603K ﹤0.01% 1176
2018
Q3
$1.88M Sell
30,302
-8,872
-23% -$539K ﹤0.01% 1147
2018
Q2
$2.11M Sell
39,174
-8,425
-18% -$421K ﹤0.01% 1108
2018
Q1
$2.17M Buy
47,599
+7,367
+18% +$316K ﹤0.01% 1053
2017
Q4
$1.58M Buy
+40,232
New +$1.53M ﹤0.01% 1125

Other funds holding EHC

Amundi Asset Management US's EHC Position: Q4 2020 in Review

Amundi Asset Management US sold out of Encompass Health (EHC) in Q4 2020, closing a stake of 173 shares — an estimated $9K sold.

Amundi Asset Management US first reported a position in EHC in Q4 2017 and held it in 12 quarters. The position peaked at $2.17M in Q1 2018. 404 funds tracked by Wall St. Rank hold EHC as of Q4 2020.

  • Amundi Asset Management US reported no remaining Encompass Health position as of Q4 2020 after selling out during the quarter.
  • Amundi Asset Management US sold 173 Encompass Health shares in Q4 2020, an estimated $9K.
  • Amundi Asset Management US first reported a position in Encompass Health in Q4 2017 and held it in 12 quarters.
  • Amundi Asset Management US's Encompass Health position peaked at $2.17M in Q1 2018.
  • 404 funds tracked by Wall St. Rank held Encompass Health as of Q4 2020.

Based on Amundi Asset Management US's 13F filing for Q4 2020, filed 16 Feb 2021.